Published in J Cell Biochem on October 01, 1997
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer (2009) 3.90
Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett (2008) 2.13
The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys (2010) 1.98
Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors. J Biol Chem (2008) 1.80
New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol (2014) 1.53
EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer (2001) 1.41
Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis (2003) 1.21
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol (2001) 1.16
Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer (2010) 1.13
Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor. Int J Cancer (2008) 1.06
(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis (2008) 1.04
Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol (2015) 1.03
Chemoprevention of head and neck cancer with green tea polyphenols. Cancer Prev Res (Phila) (2010) 1.00
Red orange: experimental models and epidemiological evidence of its benefits on human health. Oxid Med Cell Longev (2013) 0.98
EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PLoS One (2012) 0.97
Molecular mechanisms of green tea polyphenols. Nutr Cancer (2009) 0.95
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer. BMC Cancer (2012) 0.93
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. Int J Mol Sci (2008) 0.91
In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells. Mol Nutr Food Res (2013) 0.90
Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention. Oxid Med Cell Longev (2012) 0.87
Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance. Pharmacol Res (2010) 0.87
Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG-The Role of EGFR Signaling and "Lipid Raft". J Oncol (2011) 0.86
Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp Ther Med (2012) 0.86
Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression. Clin Cancer Res (2009) 0.85
Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol (2005) 0.84
Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway. Biomed Res Int (2015) 0.84
Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells. PLoS One (2013) 0.81
Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols. Pharmacol Res (2012) 0.80
The modulation of endothelial cell gene expression by green tea polyphenol-EGCG. Mol Nutr Food Res (2008) 0.80
Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+. J Zhejiang Univ Sci B (2005) 0.79
Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prev Res (Phila) (2014) 0.79
Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells. Oxid Med Cell Longev (2015) 0.79
Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process. Eur J Nutr (2010) 0.78
Prevention of coronary heart disease and cancer by tea, a review. Environ Health Prev Med (2003) 0.77
Epigallocatechin Gallate Remodels overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment. J Biol Chem (2016) 0.75
Both Phenolic and Non-phenolic Green Tea Fractions Inhibit Migration of Cancer Cells. Front Pharmacol (2016) 0.75
Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention. Transl Med (Sunnyvale) (2012) 0.75
Potential Benefits of Jujube (Zizyphus Lotus L.) Bioactive Compounds for Nutrition and Health. J Nutr Metab (2016) 0.75
ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases. J Oncol (2017) 0.75
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges. Antioxidants (Basel) (2017) 0.75
Epigallocatechin-3-gallate augments the therapeutic effects of benzo[a]pyrene-mediated lung carcinogenesis. Biofactors (2017) 0.75
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res (2001) 5.78
Aberrant subcellular localization of BRCA1 in breast cancer. Science (1995) 3.61
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science (1999) 3.47
Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos (1999) 3.30
Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11
The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci U S A (1998) 2.85
Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal (1997) 2.77
BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res (1996) 2.04
Effect of aging on gender differences in neural control of heart rate. Am J Physiol (1999) 2.02
Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol (1998) 1.95
2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res (1977) 1.88
Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol (2000) 1.74
Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol (1999) 1.72
Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer (1999) 1.68
Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res (1977) 1.67
Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis (1999) 1.67
Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression. Mol Cell Biol (1995) 1.67
(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol (1997) 1.55
Local thermal stimulation relaxes hypertonic anal sphincter: evidence of somatoanal reflex. Dis Colon Rectum (1999) 1.54
Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci U S A (1991) 1.53
Chromophoric labeling of amino acids with 4-dimethylaminoazobenzene-4'-sulfonyl chloride. Anal Chem (1975) 1.50
Experimental podophyllotoxin (bajiaolian) poisoning: I. Effects on the nervous system. Biomed Environ Sci (1992) 1.48
Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol (2000) 1.48
A new method for clitoroplasty in male-to-female sex reassignment surgery. Plast Reconstr Surg (1992) 1.44
De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol (2001) 1.39
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis (2000) 1.34
Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J Cell Biochem (1999) 1.34
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta (1996) 1.33
Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol (1994) 1.31
Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs. J Biol Chem (1998) 1.21
Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett (2001) 1.21
Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol (2000) 1.20
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett (2001) 1.20
Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol (2000) 1.17
Using molecular markers and multivariate methods to study the genetic diversity of local European and Asian chicken breeds. Anim Genet (2008) 1.15
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer (1996) 1.14
Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol Pharmacol (2001) 1.13
Trend of large bowel tuberculosis and the relation with pulmonary tuberculosis. Dis Colon Rectum (1992) 1.10
Cytotoxic activities of tanshinones against human carcinoma cell lines. Am J Chin Med (1991) 1.10
Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int J Cancer (2001) 1.08
Growth inhibitors against tumor cells in Cordyceps sinensis other than cordycepin and polysaccharides. Cancer Invest (1994) 1.08
Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation. Eur Respir J (2003) 1.06
Enterovesical fistula: 10 years experience. Zhonghua Yi Xue Za Zhi (Taipei) (1997) 1.06
Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis. Life Sci (2000) 1.04
Acute toxicity of PR toxin, a mycotoxin from Penicillium roqueforti. Toxicon (1982) 1.04
Cordyceps sinensis as an immunomodulatory agent. Am J Chin Med (1996) 1.03
Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc Natl Sci Counc Repub China B (1995) 1.02
Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats. Planta Med (1999) 1.02
Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate. Carcinogenesis (1999) 1.02
The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem (2000) 1.01
Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis (1993) 1.01
Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem (2001) 1.01
Determination of the components in a Chinese prescription, yu-ping-feng san, by RAPD analysis. Planta Med (1998) 0.99
Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Brain Res (1999) 0.99
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol (2000) 0.99
Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog (1996) 0.97
Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene (1998) 0.97
Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur J Pharmacol (1991) 0.96
Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J Ethnopharmacol (1997) 0.96
Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. Eur J Pharmacol (1999) 0.96
Vasorelaxing effect of coumarins from Cnidium monnieri on rabbit corpus cavernosum. Planta Med (2001) 0.95
Vasorelaxant effect of harman. Eur J Pharmacol (2000) 0.95
Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide. Br J Pharmacol (1998) 0.95
Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology (1998) 0.94
Local somatothermal stimulation inhibits motility of the internal anal sphincter through nitrergic neural release of nitric oxide. Dis Colon Rectum (2000) 0.94
[Factors related to the choice of clinic between Chinese traditional medicine and Western medicine]. J Formos Med Assoc (1994) 0.94
Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br J Pharmacol (2000) 0.93
Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene. Cancer Res (1975) 0.93
Age-period-cohort analysis of breast cancer mortality. Anticancer Res (1995) 0.92
Thyroid hormone, T3-dependent phosphorylation and translocation of Trip230 from the Golgi complex to the nucleus. Proc Natl Acad Sci U S A (1999) 0.92
Antitumor agent, physalin F from Physalis angulata L. Anticancer Res (1992) 0.92
Topology of feather melanocyte progenitor niche allows complex pigment patterns to emerge. Science (2013) 0.92
Identification of cellular TSG101 protein in multiple human breast cancer cell lines. Cancer Res (1997) 0.92
Effects of Gastrodia elata and its active constituents on scopolamine-induced amnesia in rats. Planta Med (1996) 0.92
A global analysis of molecular markers and phenotypic traits in local chicken breeds in Taiwan. Anim Genet (2011) 0.92
Neural mechanisms of impaired micturition reflex in rats with acute partial bladder outlet obstruction. Neuroscience (2000) 0.92
Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med (2000) 0.92
Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J Nat Prod (1997) 0.91
Leiomyosarcoma of the rectum: a series of twelve cases. Zhonghua Yi Xue Za Zhi (Taipei) (1996) 0.91
Concentration and regional distribution of propofol in brain and spinal cord during propofol anesthesia in the rat. Neurosci Lett (1995) 0.91
Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. Eur J Pharmacol (1999) 0.91
Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography. J Chromatogr B Biomed Appl (1994) 0.91
Death signaling pathway induced by pyrrolidine dithiocarbamate-Cu(2+) complex in the cultured rat cortical astrocytes. Glia (2000) 0.91
Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro. Hepatology (1996) 0.91
Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene (1996) 0.91
The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur J Pharmacol (1992) 0.90
Colonoscopy in abdominal actinomycosis. Gastrointest Endosc (2000) 0.90
N-substitution of carbon 8 in guanosine and deoxyguanosine by the carcinogen N-benzoyloxy-N-methyl-4-aminoazobenzene in vitro. Cancer Res (1975) 0.90
Inhibitory effect of digoxin on testosterone secretion through mechanisms involving decreases of cyclic AMP production and cytochrome P450scc activity in rat testicular interstitial cells. Br J Pharmacol (1998) 0.90
Significance of nm23 mRNA expression in human hepatocellular carcinoma. Anticancer Res (1998) 0.90
Risk and patterns of brain metastases in colorectal cancer: 27-year experience. Dis Colon Rectum (1999) 0.90
Magnolol inhibits Mac-1 (CD11b/CD18)-dependent neutrophil adhesion: relationship with its antioxidant effect. Eur J Pharmacol (1998) 0.90
Inhibition of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells. Carcinogenesis (1993) 0.89
The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study. Br J Pharmacol (2002) 0.89
Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina. Eur J Pharmacol (1998) 0.89
Activation of transcription factors of nuclear factor kappa B, activator protein-1 and octamer factors in hyperalgesia. Eur J Pharmacol (2000) 0.89
Primary vs. delayed resection for obstructive left-sided colorectal cancer: impact of surgery on patient outcome. Dis Colon Rectum (2008) 0.89
Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Oncology (2000) 0.89